特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

モノクローナル抗体の世界市場 - 考察と予測、COVID-19の潜在的影響:2020年~2024年

Global Monoclonal Antibodies Market (By Source, Application, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

発行 Koncept Analytics 商品コード 950619
出版日 ページ情報 英文 128 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
モノクローナル抗体の世界市場 - 考察と予測、COVID-19の潜在的影響:2020年~2024年 Global Monoclonal Antibodies Market (By Source, Application, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
出版日: 2020年07月21日 ページ情報: 英文 128 Pages
概要

世界のモノクローナル抗体市場は、2024年に1,617億米ドルに達し、2020年~2024年のCAGRで7.21%の成長が予測されています。市場の成長促進要因として、新しいがん症例の発生率の増加、生物製剤の売上の増加、老年人口の拡大、医薬品R&D費の増加、糖尿病の有病数の上昇、医療費の急増などが挙げられます。

当レポートでは、世界のモノクローナル抗体市場について調査分析し、市場規模、市場力学、競合情勢、主要企業など、体系的な情報を提供しています。

目次

第1章 概要

  • イントロダクション
  • モノクローナル抗体の種類
  • モノクローナル抗体の由来
  • モノクローナル抗体の利点と欠点
  • モノクローナル抗体の応用
  • モノクローナル抗体の製造プロセス

第2章 COVID-19の影響

  • COVID-19による死者数の増加
  • 政府の医療支出の増加
  • 血漿療法の採用
  • COVID-19モノクローナル抗体候補薬の治験

第3章 世界の市場分析

  • 世界のモノクローナル抗体市場:金額別
  • 世界のモノクローナル抗体市場予測:金額別
  • 世界のモノクローナル抗体市場金額:由来別
  • 世界のモノクローナル抗体市場金額:適応症別
  • 世界のモノクローナル抗体市場金額:エンドユーザー別
  • 世界のモノクローナル抗体の生産量と需要量
  • 世界のモノクローナル抗体市場金額:地域別

第4章 地域別の市場分析

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第5章 市場力学

  • 成長促進要因
  • 主な動向と開発
  • 課題

第6章 競合情勢

  • 世界市場
    • 主要企業:収益比較
    • 主要企業:R&D費の比較
    • 主要企業:時価総額の比較

第7章 企業プロファイル

  • Johnson & Johnson
  • Novartis AG
  • Merck and Co.
  • AbbVie Inc.
  • Bristol-Myers Squibb
  • Amgen AG
図表

List of Figures

  • Types of Monoclonal Antibodies
  • Source of Monoclonal Antibodies
  • Monoclonal Antibodies Applications
  • Monoclonal Antibody Production Process
  • Global Government Share on Health Spending (2019-2024)
  • Global Plasma Therapy Market Forecast (2019-2024)
  • Global Monoclonal Antibodies Market by Value (2015-2019)
  • Global Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Monoclonal Antibodies Market Value by Source (2019)
  • Global Humanized Monoclonal Antibodies Market by Value (2015-2019)
  • Global Humanized Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Human Monoclonal Antibodies Market by Value (2015-2019)
  • Global Human Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Chimeric Monoclonal Antibodies Market by Value (2015-2019)
  • Global Chimeric Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Murine Monoclonal Antibodies Market by Value (2015-2019)
  • Global Murine Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Monoclonal Antibodies Market Value by Indication (2019)
  • Global Cancer Monoclonal Antibodies Market by Value (2015-2019)
  • Global Cancer Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Autoimmune Diseases Monoclonal Antibodies Market by Value (2015-2019)
  • Global Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Infectious Diseases Monoclonal Antibodies Market by Value (2015-2019)
  • Global Infectious Diseases Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Monoclonal Antibodies Market Value by End-Users (2019)
  • Global Hospital Monoclonal Antibodies Market by Value (2015-2019)
  • Global Hospital Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Research Institutes Monoclonal Antibodies Market by Value (2015-2019)
  • Global Research Institutes Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Monoclonal Antibodies Capacity and Demand Volume (2015-2024)
  • Global Monoclonal Antibodies Market Value by Region (2019)
  • North America Monoclonal Antibodies Market by Value (2015-2019)
  • North America Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • North America Monoclonal Antibodies Market by Region (2019)
  • The U.S. Monoclonal Antibodies Market by Value (2015-2019)
  • The U.S. Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • The U.S. Monoclonal Antibodies Market by Application (2019)
  • The U.S. Cancer Monoclonal Antibodies Market by Value (2015-2019)
  • The U.S. Cancer Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • The U.S. Autoimmune Diseases Monoclonal Antibodies Market by Value (2015-2019)
  • The U.S. Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • The U.S. Infectious Diseases Monoclonal Antibodies Market by Value (2015-2019)
  • The U.S. Infectious Diseases Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Europe Monoclonal Antibodies Market by Value (2015-2019)
  • Europe Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Asia Pacific Monoclonal Antibodies Market by Value (2015-2019)
  • Asia Pacific Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Latin America Monoclonal Antibodies Market by Value (2015-2019)
  • Latin America Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Middle East & Africa Monoclonal Antibodies Market by Value (2015-2019)
  • Middle East & Africa Antiviral Drugs Market Forecast by Value (2020-2024)
  • Global New Cases of Top Cancer Types (2019)
  • Global Biologics Market (2015-2019)
  • Global Geriatric Population - Age 65 and Above (2015-2019)
  • Global Pharmaceutical R&D Spending (2015-2019)
  • Global Diabetic Population by Top Countries (2019)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Growth Rate of Infectious Diseases Forecast (2017-2022)
  • Global Pharmaceutical and Biotech M&A (2015-2019)
  • FDA-Approved Monoclonal Antibodies (2019)
  • Johnson & Johnson Total Sales and Net Earnings (2015-2019)
  • Johnson & Johnson Total Sales by Segments (2019)
  • Johnson & Johnson Total Sales by Regions (2019)
  • Novartis AG Net Sales and Net Income (2015-2019)
  • Novartis AG Net Sales by Segments (2019)
  • Novartis AG Net Sales by Regions (2019)
  • Merck and Co. Sales and Net Income (2015-2019)
  • Merck and Co. Sales by Segments (2019)
  • Merck and Co. Sales by Regions (2019)
  • AbbVie Inc. Net Revenue and Net Earnings (2015-2019)
  • AbbVie Inc. Net Revenue by Product (2019)
  • AbbVie Inc. Net Revenue by Regions (2019)
  • Bristol-Myers Squibb Total Revenue and Net Earnings (2015-2019)
  • Bristol-Myers Squibb Total Revenue by Operations (2019)
  • Bristol-Myers Squibb Total Revenue by Regions (2019)
  • Amgen AG Total Revenue and Net Income (2015-2019)
  • Amgen AG Total Revenue by Divisions (2019)
  • Amgen AG Total Revenue by Regions (2019)

List of Tables

  • Advantages and Disadvantages of Monoclonal Antibodies
  • Global COVID-19 Confirmed Deaths (2020)
  • COVID-19 Monoclonal Antibody Candidate Drugs in Phase III-IV Trials
  • Key Players - Revenue Comparison (2019)
  • Key Players - R&D Expenditure Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)
目次

The global monoclonal antibodies market is expected to reach US$161.7 billion in 2024, increasing at a CAGR of 7.21%, for the duration of 2020-2024. The factors such as, increasing incidences of new cancer cases, escalating sales of biologics, growth in geriatric population, increasing pharmaceutical R&D spending, rise in prevalence of diabetes and upsurge in healthcare expenditure would drive the growth of the market. However, the market growth would be challenged by high cost involved in the development of the therapeutic monoclonal antibodies, threats associated with drugs counterfeiting and legal regulations. A few notable trends include accelerating growth rates of infectious diseases, growth in the pharmaceutical & biotechnology M&A, development of new monoclonal antibodies and emergence of stereo-specific monoclonal antibodies.

The global monoclonal antibodies market is very lucrative as there is wide scope for its application for various indications. The rising prevalence of cancer is leading to the demand for humanized monoclonal antibodies as such class of drugs can target cancer cell at rapid speed as well as reduce their multiplication. In addition, monoclonal antibodies have found application in research and development of various novel drugs as well as therapies, which is providing a great opportunity for its market growth across the world.

The fastest growing regional market is North America due to the presence of biopharmaceutical key players and the well-established healthcare infrastructure. It is followed by Europe and Asia Pacific, which also hold considerable share in the global market, owing to the increased application of monoclonal antibodies. Further, the rising number of coronavirus cases is augmenting the need for precise therapeutic options, which is leading to the development of mono-specific and thereby would help the monoclonal antibodies market to grow considerably in coming year.

Scope of the report:

  • The report provides a comprehensive analysis of the global monoclonal antibodies market.
  • The major regional markets (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson, Novartis AG, Merck & Co., AbbVie Inc., Bristol-Myer Squibb and Amgen AG) are also presented in detail.

Key Target Audience:

  • Monoclonal Antibodies Manufacturers
  • Pharmaceuticals and Biopharmaceutical Firms
  • End Users (Hospitals and Research Institutes)
  • Investment Banks
  • Healthcare and Medical Consultants.
  • Government Bodies & Regulating Authorities

Table of Contents

1. Overview

  • 1.1 Introduction
  • 1.2 Types of Monoclonal Antibodies
  • 1.3 Source of Monoclonal Antibodies
  • 1.4 Advantages and Disadvantages of Monoclonal Antibodies
  • 1.5 Monoclonal Antibodies Applications
  • 1.6 Monoclonal Antibody Production Process

2. Impact of COVID-19

  • 2.1 Rise in COVID-19 Death Toll
  • 2.2 Growth in Government Spending on Healthcare
  • 2.3 Adoption of Plasma Therapy
  • 2.4 COVID-19 Monoclonal Antibody Candidate Drugs in Trial

3. Global Market Analysis

  • 3.1 Global Monoclonal Antibodies Market by Value
  • 3.2 Global Monoclonal Antibodies Market Forecast by Value
  • 3.3 Global Monoclonal Antibodies Market Value by Source
    • 3.3.1 Global Humanized Monoclonal Antibodies Market by Value
    • 3.3.2 Global Humanized Monoclonal Antibodies Market Forecast by Value
    • 3.3.3 Global Human Monoclonal Antibodies Market by Value
    • 3.3.4 Global Human Monoclonal Antibodies Market Forecast by Value
    • 3.3.5 Global Chimeric Monoclonal Antibodies Market by Value
    • 3.3.6 Global Chimeric Monoclonal Antibodies Market Forecast by Value
    • 3.3.7 Global Murine Monoclonal Antibodies Market by Value
    • 3.3.8 Global Murine Monoclonal Antibodies Market Forecast by Value
  • 3.4 Global Monoclonal Antibodies Market Value by Indication
    • 3.4.1 Global Cancer Monoclonal Antibodies Market by Value
    • 3.4.2 Global Cancer Monoclonal Antibodies Market Forecast by Value
    • 3.4.3 Global Autoimmune Diseases Monoclonal Antibodies Market by Value
    • 3.4.4 Global Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value
    • 3.4.5 Global Infectious Diseases Monoclonal Antibodies Market by Value
    • 3.4.6 Global Infectious Diseases Monoclonal Antibodies Market Forecast by Value
  • 3.5 Global Monoclonal Antibodies Market Value by End-Users
    • 3.5.1 Global Hospital Monoclonal Antibodies Market by Value
    • 3.5.2 Global Hospital Monoclonal Antibodies Market Forecast by Value
    • 3.5.3 Global Research Institutes Monoclonal Antibodies Market by Value
    • 3.5.4 Global Research Institutes Monoclonal Antibodies Market Forecast by Value
  • 3.6 Global Monoclonal Antibodies Capacity and Demand Volume
  • 3.7 Global Monoclonal Antibodies Market Value by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Monoclonal Antibodies Market by Value
    • 4.1.2 North America Monoclonal Antibodies Market Forecast by Value
    • 4.1.3 North America Monoclonal Antibodies Market by Region
    • 4.1.4 The U.S. Monoclonal Antibodies Market by Value
    • 4.1.5 The U.S. Monoclonal Antibodies Market Forecast by Value
    • 4.1.6 The U.S. Monoclonal Antibodies Market by Application
    • 4.1.7 The U.S. Cancer Monoclonal Antibodies Market by Value
    • 4.1.8 The U.S. Cancer Monoclonal Antibodies Market Forecast by Value
    • 4.1.9 The U.S. Autoimmune Diseases Monoclonal Antibodies Market by Value
    • 4.1.10 The U.S. Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value
    • 4.1.11 The U.S. Infectious Diseases Monoclonal Antibodies Market by Value
    • 4.1.12 The U.S. Infectious Diseases Monoclonal Antibodies Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Monoclonal Antibodies Market by Value
    • 4.2.2 Europe Monoclonal Antibodies Market Forecast by Value
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Monoclonal Antibodies Market by Value
    • 4.3.2 Asia Pacific Monoclonal Antibodies Market Forecast by Value
  • 4.4 Latin America
    • 4.4.1 Latin America Monoclonal Antibodies Market by Value
    • 4.4.2 Latin America Monoclonal Antibodies Market Forecast by Value
  • 4.4 Middle East & Africa
    • 4.5.1 Middle East & Africa Monoclonal Antibodies Market by Value
    • 4.5.2 Middle East & Monoclonal Antibodies Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Rising Incidences of New Cancer Cases
    • 5.1.2 Escalating Sales of Biologics
    • 5.1.3 Growth in Geriatric Population
    • 5.1.4 Increasing Pharmaceutical R&D Spending
    • 5.1.5 Rise in Prevalence of Diabetes
    • 5.1.6 Upsurge in Healthcare Expenditures
  • 5.2 Key Trends and Developments
    • 5.2.1 Accelerating Growth Rates of Infectious Diseases
    • 5.2.2 Growth in Pharmaceutical and Biotech Merger & Acquisition
    • 5.2.3 Development of New Monoclonal Antibodies
    • 5.2.4 Emergence of Stereo-specific Monoclonal Antibodies
  • 5.3 Challenges
    • 5.3.1 High Cost Involved
    • 5.3.2 Threats Associated with Drugs Counterfeiting
    • 5.3.3 Legal Regulations
  • 6.Competitive Landscape
  • 6.1 Global Market
    • 6.1.1 Key Players - Revenue Comparison
    • 6.1.2 Key Players - R&D Expenditure Comparison
    • 6.1.3 Key Players - Market Capitalization Comparison

7. Company Profiles

  • 7.1 Johnson & Johnson
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Novartis AG
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Merck and Co.
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 AbbVie Inc.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Bristol-Myers Squibb
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 Amgen AG
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies